Loading...
XSHG603301
Market cap814mUSD
Dec 24, Last price  
22.42CNY
1D
1.13%
1Q
8.52%
IPO
-41.00%
Name

ZHENDE MEDICAL CO LTD

Chart & Performance

D1W1MN
XSHG:603301 chart
P/E
29.96
P/S
1.44
EPS
0.75
Div Yield, %
7.13%
Shrs. gr., 5y
8.24%
Rev. gr., 5y
23.63%
Revenues
4.13b
-32.76%
986,914,9901,021,012,4171,034,899,3121,306,442,5401,428,856,6841,867,727,91510,398,545,6385,091,572,4476,137,634,4314,127,044,055
Net income
198m
-70.82%
21,774,56079,059,48282,841,569121,769,114130,203,577156,890,0612,549,453,200595,861,926679,878,142198,399,010
CFO
452m
-63.72%
83,626,714142,699,376138,574,134182,343,95720,245,774197,762,7363,120,839,894817,629,3181,246,045,055452,107,162
Dividend
Jul 03, 20240.5 CNY/sh
Earnings
May 20, 2025

Profile

Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment. It offers medical wound dressing products, sensory control protection products, pressure therapy and immobilization products, and stoma and chronic wounds, and home care products. The company sells its products approximately in 73 countries, including Europe, the United States, and China. The company was founded in 1994 and is based in Shaoxing, China.
URL
http://www.zhende.com/
IPO date
Apr 12, 2018
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
4,127,044
-32.76%
6,137,634
20.54%
5,091,572
-51.04%
Cost of revenue
3,489,890
4,835,827
3,985,599
Unusual Expense (Income)
NOPBT
637,154
1,301,807
1,105,973
NOPBT Margin
15.44%
21.21%
21.72%
Operating Taxes
5,492
98,704
99,002
Tax Rate
0.86%
7.58%
8.95%
NOPAT
631,661
1,203,103
1,006,971
Net income
198,399
-70.82%
679,878
14.10%
595,862
-76.63%
Dividends
(423,716)
(136,323)
(522,571)
Dividend yield
6.45%
1.51%
4.49%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
220,145
139,128
670,473
Long-term debt
278,625
461,974
210,620
Deferred revenue
231,984
176,001
173,902
Other long-term liabilities
1
1
1
Net debt
(748,087)
(1,611,817)
(562,039)
Cash flow
Cash from operating activities
452,107
1,246,045
817,629
CAPEX
(599,235)
Cash from investing activities
(1,057,854)
Cash from financing activities
(423,284)
455,998
FCF
333,267
1,172,740
426,583
Balance
Cash
1,207,412
2,174,775
1,363,521
Long term investments
39,445
38,144
79,611
Excess cash
1,040,504
1,906,037
1,188,554
Stockholders' equity
3,648,974
3,993,529
3,559,250
Invested Capital
5,255,420
4,468,044
4,243,161
ROIC
12.99%
27.62%
26.99%
ROCE
10.09%
20.36%
20.26%
EV
Common stock shares outstanding
268,107
237,328
226,563
Price
24.52
-35.56%
38.05
-25.93%
51.37
-17.85%
Market cap
6,573,978
-27.20%
9,030,347
-22.41%
11,638,565
-8.74%
EV
6,064,695
7,633,846
11,449,386
EBITDA
880,122
1,496,085
1,247,941
EV/EBITDA
6.89
5.10
9.17
Interest
30,913
33,539
25,073
Interest/NOPBT
4.85%
2.58%
2.27%